about
sameAs
Centriole assembly and the role of Mps1: defensible or dispensable?Cdc2: a monopotent or pluripotent CDK?Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signalingCDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanismsDifferentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activityAb ovo or de novo? Mechanisms of centriole duplicationPreventing re-replication of chromosomal DNA.Cyclin dependent kinase 2 and the regulation of human progesterone receptor activitySpecialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factorTransforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor proteinLow-molecular-weight cyclin E: the missing link between biology and clinical outcomeTransforming growth factor beta-1 decreases the yield of the second meiotic division of rat pachytene spermatocytes in vitroAn oncologist׳s friend: How Xenopus contributes to cancer researchLoss of the Greatwall Kinase Weakens the Spindle Assembly CheckpointParkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.Essential role of the Cdk2 activator RingoA in meiotic telomere tethering to the nuclear envelope.Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer ActivitiesTargeting the RB-E2F pathway in breast cancerTargeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancersStructural and functional adaptations of the mammalian nuclear envelope to meet the meiotic requirementsFoxp3 protein stability is regulated by cyclin-dependent kinase 2Fancf-deficient mice are prone to develop ovarian tumoursDrugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsFifteen-year quest for microphthalmia-associated transcription factor target genesThe concept of synthetic lethality in the context of anticancer therapyCyclin A/cdk2 coordinates centrosomal and nuclear mitotic eventsAntiviral activity of CYC202 in HIV-1-infected cellsChemical genetics reveals a specific requirement for Cdk2 activity in the DNA damage response and identifies Nbs1 as a Cdk2 substrate in human cellsMolecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin EPhosphorylation of Kif26b promotes its polyubiquitination and subsequent proteasomal degradation during kidney developmentMastl is required for timely activation of APC/C in meiosis I and Cdk1 reactivation in meiosis IIKidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneysCyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regenerationFailure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell developmentCyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cellsThe histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cyclesImpaired mitotic progression and preimplantation lethality in mice lacking OMCG1, a new evolutionarily conserved nuclear proteinOverexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activationMiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.Chromatin decondensation in S-phase involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation
P2860
Q21203546-92494CDA-9506-49CC-A262-1E0DD7E01727Q24300976-212A8BF5-2395-4CA9-A2BB-E91959733FC1Q24301328-748080CC-6CD0-4308-B411-21E58CD16FD9Q24302257-B12F6550-8085-40F4-9594-84F487A7C1EAQ24644745-5533DDF6-26F1-4E07-83BC-EC984DF3D0BAQ24650428-6D971074-0DB9-4872-9367-9E3098203C92Q24653685-86B2A9EC-7DBB-4E36-AD19-92837A6ECDB0Q24678662-B003A74B-0729-42C9-9809-28E2B52E3CD2Q24681581-984E60DD-EABF-4935-B93C-71BE81F930B2Q24794459-50BA045A-B751-41F8-AD10-827D46D7090FQ24806316-B2CE5EA6-8835-4412-961C-767B16F0E680Q24811554-DCD7EFD4-B2DF-4512-ADCA-39E4B5861EF9Q26849774-02746D2E-C815-49B1-B087-4A5315023A63Q27307873-8FEF59E9-74B1-4FBC-97AF-2FE97B8713AAQ27308731-6CA4DE95-D22F-442E-8A82-5B5F5E35AA37Q27322817-5E502860-85ED-41FD-BC4E-BCF829C77505Q27675842-24FD7508-85E7-4372-8F61-0383FB36482DQ28069626-8CB2DE3D-84E2-4453-ACB7-191F7B30A9ADQ28069910-6965CF39-46D1-480D-87B4-EB518AF9D534Q28082743-8760CFF6-1CA1-4591-8366-B30A85C5B569Q28117202-9B8F66B0-3FA3-4B4E-B6AA-432CE918754AQ28247935-AE1B46AF-A9BD-4DA5-A75E-02909B892A8EQ28254233-53A7644D-BAFE-4DF3-8059-EE194AC1C01DQ28267024-4A56F877-1950-4B1A-846E-1EB384B99643Q28268061-57396595-4C3A-4318-85C9-CEA7C1B6BE89Q28274303-E21479EE-5CAC-4896-8088-8DF62B6F568AQ28292152-8C6B8810-D252-4EA2-B000-308A9BCD9AC0Q28482509-8203B5B8-F46C-4859-84A7-4011170D85B0Q28486255-499988C4-E7DE-49D4-B20F-D7FCCE6196A3Q28506566-AD3D63FD-DA9A-4414-8EE7-7120EEF370BCQ28507240-207753BE-C92E-4A1D-9FA2-9B106694A6C1Q28513499-86CCD832-6981-4103-9E9E-8B35EDD06AD3Q28573711-E1560B7E-851B-4280-AF07-49EF34FA1451Q28585216-8427590B-83E0-410A-84D9-C032992A627AQ28585746-0D7E8FD8-745A-4603-98F4-B75114BEB544Q28588582-5433176E-01B0-4664-8E71-7A0E339E4A7CQ28595006-009C770F-2457-453C-B219-8907FBAEE09FQ28941776-64E314B4-4CBE-4E66-9011-94B24D0436A0Q30434790-64F89DFA-CB03-407B-A644-57F19603AB27Q30436174-69E243C8-F859-45AE-8D8F-F81AF89482BA
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cdk2 knockout mice are viable
@ast
Cdk2 knockout mice are viable
@en
Cdk2 knockout mice are viable
@nl
type
label
Cdk2 knockout mice are viable
@ast
Cdk2 knockout mice are viable
@en
Cdk2 knockout mice are viable
@nl
prefLabel
Cdk2 knockout mice are viable
@ast
Cdk2 knockout mice are viable
@en
Cdk2 knockout mice are viable
@nl
P2093
P3181
P1433
P1476
Cdk2 knockout mice are viable
@en
P2093
Cyril Berthet
Eiman Aleem
Lino Tessarollo
Philipp Kaldis
Vincenzo Coppola
P304
P3181
P356
10.1016/J.CUB.2003.09.024
P407
P577
2003-10-14T00:00:00Z